Clinical trials
Growth clinical trials
Below are recruiting growth clinical trials, each written for real people, not researchers. We’re tracking 295 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07272122RecruitingPhase 3
Reducing flies to lower illness in camps
This trial tests a method to reduce fly populations in camp settings to see if it can lower the spread of germs that cause diarrhea. The goal is to find a low-tech way to keep families healthier.
Bunj, Maban CountyAges 1 year+ - NCT07263490Recruiting
Pre-eclampsia Risk in Egg Recipients Study
This study looks at whether women who become pregnant after receiving donated eggs have a higher risk of developing pre-eclampsia (a serious blood pressure condition) during pregnancy. It aims to understand risks so doctors can better support pregnant women.
CopenhagenAges 18 years+ - NCT06050200Recruiting
Growth Observation in Liver Surgery
This trial studies a way to help people who need liver surgery but have a very small remaining liver after the operation. It tests a special growth observation approach to see if it can safely increase the size of the future liver remnant.
Warsaw, Masovian VoivodeshipAges 18–80 - NCT07249216Recruiting
Studying eye fluid to improve treatment for wet age-related macular degeneration
This study looks at whether certain proteins or molecules in the jelly-like fluid inside the eye can predict why some people with wet age-related macular degeneration do not respond well to standard anti-VEGF injections. By studying these signals, researchers hope to improve future treatment and better tailor care to individual patients.
SingaporeAges 50 years+ - NCT07247123Recruiting
Skin cancer self-check education program
This trial tests a new educational program to help people learn how to check their own skin for signs of skin cancer. It aims to make early detection easier, and you can join regardless of whether you have had skin cancer before.
SingaporeAges 16 years+ - NCT07231705Recruiting
Plant-based formula for growth and tolerance in toddlers
This study tests how well toddlers (12-17 months old) tolerate and grow on a plant-based formula. It compares this new formula to standard ones for children who get most of their calories from formula.
Columbus, OhioAges 1 year–1.4 years - NCT07222215RecruitingPhase 2
Capacitabine with or without elacestrant for ER+ breast cancer
This trial tests if adding a new oral targeted therapy (elacestrant) to standard chemotherapy (capecitabine) works better than chemotherapy alone for people with a specific type of advanced breast cancer that is hormone-sensitive (ER-positive) and has stopped responding to hormone therapy.
Boston, MassachusettsAges 18 years+ - NCT07224555Enrolling by invitation
A gummy supplement for women with thinning hair
This study tests whether a daily gummy supplement called Xtressé can help with self-perceived thinning hair in women. If you are a woman between 18 and 65 who feels your hair is thinning, this trial may help determine if the supplement is effective for you.
Maitland, FloridaAges 18–65 - NCT06918236Recruiting
Pregnancy after fertility treatment: study of outcomes
This study looks at pregnancy results for women who had fertility treatments (like IVF). You can join if your baby is alive on ultrasound and you are between 11 and 14 weeks pregnant.
PlevenAges 18 years+ - NCT07191717RecruitingPhase 2
Imlunestrant and abemaciclib for early ER+ breast cancer
This trial tests whether adding two targeted drugs, imlunestrant and abemaciclib, to your usual hormone therapy can lower the chance of your breast cancer coming back. It is for people with early-stage ER+ breast cancer who have no signs of cancer on scans but have tiny amounts of tumor DNA in their blood (called ctDNA).
Los Angeles, CaliforniaAges 18 years+ - NCT06952777Recruiting
Testing sensors to monitor babies in the womb
This study tests new sensors to check on a baby's wellbeing during the third trimester of pregnancy, as an alternative to standard monitors. You would wear a sensor on your belly to track your baby's heartbeat and movements without wires or needles.
ManchesterAges 16–50 - NCT07152106Recruiting
Amniotic fluid and the preterm baby's gut
This study looks at the fluid around your baby (amniotic fluid) and how it might affect your baby's gut health if they are born early. It may help doctors understand how to better care for preterm infants.
AmsterdamAges 16 years+ - NCT07143045Recruiting
Zorifertinib for lung cancer that has spread to the brain
This trial tracks how well zorifertinib works as a first treatment for people with a specific type of advanced lung cancer that has spread to the brain or spinal cord lining. Participants may receive zorifertinib or another standard treatment, and researchers will monitor their response over time.
Hefei, AnhuiAges 18 years+ - NCT07142135Enrolling by invitation
Long-term follow-up for Klinefelter syndrome patients
This study follows patients with Klinefelter syndrome over time to learn more about their health. It may help doctors better understand and care for people with this condition.
CopenhagenAges Any age - NCT07115108Recruiting
High-energy feeding for growth and brain development in infants with heart disease
This study tests a special high-energy formula for babies with congenital heart disease who are at nutritional risk. It aims to see if this feeding helps them grow and develop better before and after heart surgery.
Shanghai, Shanghai MunicipalityAges birth–6 months - NCT07098975RecruitingPhase 2
Statin for severe early-onset placental insufficiency
This trial tests if taking pravastatin (a statin) can improve blood flow to the placenta in pregnant people with either severe early-onset preeclampsia (high blood pressure) or a baby not growing well. The goal is to help the pregnancy last longer and improve outcomes.
BarcelonaAges 18 years+ - NCT07100106RecruitingPhase 1/Phase 2
Study of GDC-4198 alone or with giredestrant for advanced breast cancer
This trial tests a new treatment (GDC-4198) alone or with another drug (giredestrant) compared to a standard combination (abemaciclib and giredestrant) for people with advanced hormone receptor-positive, HER2-negative breast cancer that has progressed after previous treatments.
Huntsville, AlabamaAges 18 years+ - NCT06208397Recruiting
MRI study to understand liver tumor growth patterns
This trial uses MRI scans to study how colorectal cancer that has spread to the liver grows. It may help doctors choose better treatments.
Shenyang, LiaoningAges 18–80 - NCT07085806Recruiting
Pentoxifylline for liver growth after donor surgery
This study tests if a medicine called pentoxifylline can help your liver grow faster after donating a large part of it. You would take the medicine before and after your donor surgery.
New DelhiAges 18–55 - NCT07087782Recruiting
Early high-calorie formula for infants with single ventricle heart condition
This trial tests whether starting a special high-calorie formula (Fortini) early helps infants with a single ventricle heart condition grow better and have fewer health problems between surgeries. It might improve outcomes before their next surgery.
Corpus Christi, TexasAges birth–6 months - NCT07081230Recruiting
Albumin vs hyaluronic acid with growth factors for gum disease
This trial tests whether adding albumin or hyaluronic acid (both natural substances) to a special gum treatment helps heal gum pockets better. It is for people with moderate to advanced gum disease.
Al Mansurah, MansouraAges 25–45 - NCT07073365RecruitingPhase 2
Adding local therapy after osimertinib plus chemo for EGFR lung cancer
This trial tests whether directly treating the remaining lung tumor with surgery or radiation, after initial chemo and osimertinib, can improve outcomes for people with advanced EGFR-mutant non-small cell lung cancer.
BusanAges 20 years+ - NCT07045402Recruiting
Developmental care for preterm infants: comfort, growth, and feeding
This study tests whether a special care program including skin-to-skin contact and storytelling helps preterm babies feel more comfortable, grow better, and learn to feed by mouth sooner. It compares this extra care to the usual hospital care.
IstanbulAges 7 months–8 months - NCT07043725RecruitingPhase 3
Neoadjuvant TQB2102 for HER2-positive breast cancer
This trial tests a new drug called TQB2102 given before surgery for HER2-positive breast cancer. The goal is to see if it can shrink the tumor enough to allow a successful surgery.
Bengbu, AnhuiAges 18–75
Hear when a new Growth trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for growth?
- Yes. Clin2 currently lists 295 recruiting growth studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a growth trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a growth trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.